Comparison of Baseline Characteristics, Treatment Patterns, and In-Hospital Outcomes of Asian Versus Non-Asian White Americans With Non-ST-Segment Elevation Acute Coronary Syndromes from the CRUSADE Quality Improvement Initiative

American Journal of Cardiology

Volumn 100, Issue 3, 2007, Pages 391-396

  Wang, Tracy Y ^a   Chen, Anita Y ^a   Roe, Matthew T ^a   Alexander, Karen P ^a   Newby, L Kristin ^a   Smith Jr , Sidney C ^b   Bangalore, Sripal ^c   Gibler, W Brian ^d   Ohman, E Magnus ^a   Peterson, Eric D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ASIAN; BLEEDING; BODY MASS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE TRANSFUSION; EUROPEAN AMERICAN; FEMALE; HEART CATHETERIZATION; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK; RISK FACTOR;

AGED; ANGINA, UNSTABLE; ASIAN AMERICANS; BODY MASS INDEX; ELECTROCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TREATMENT OUTCOME; UNITED STATES;

EID: 34447629544     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.035     Document Type: Article

References (26)

1. Chen Z.M., Jiang L.X., Chen Y.P., Xie J.X., Pan H.C., Peto R., Collins R., and Liu L.S. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
2. Ross A.M., Gao R., Coyne K.S., Chen J., Yao K., Yang Y., Qin X., Qiao S., and Yao M. A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. Am Heart J 142 (2001) 244-247
3. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 106 (2002) 1893-1900
4. Reeves T.J., and Bennett C.E. The Asian and Pacific Islander Population in the United States. Current Population Reports, P20-540 (2003), US Census Bureau, Washington, DC
5. CRUSADE. Seeking to improve the evidenced-based care of NSTE ACS patients nationwide. Available at: www.crusadeqi.com. Accessed on June 11, 2007.
6. Eptifibatide Package Insert. Available at: http://www.fda.gov/cder/foi/label/2001/20718s131b1.pdf. Accessed July 10, 2007.
7. Enoxaparin Package Insert. Available at: http://www.fda.gov/medwatch/SAFETY/2003/03Jul_Pl/lovenox.pdf. Accessed on July 10, 2007.
8. Tirofiban Package Insert. Available at: http://www.fda.gov/cder/foi/label/1998/209121b1.pdf. Accessed July 10, 2007.
9. Alexander K.P., Chen A.Y., Roe M.T., Newby L.K., Gibson C.M., Allen-LaPointe N.M., Pollack C., Gibler W.B., Ohman E.M., and Peterson E.D. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 294 (2005) 3108-3116
10. Zeger S.L., and Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130
11. Boersma E., Pieper K.S., Steyerberg E.W., Wilcox R.G., Chang W.C., Lee K.L., Akkerhuis K.M., Harrington R.A., Deckers J.W., Armstrong P.W., et al., The PURSUIT Investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation 101 (2000) 2557-2567
12. Moscucci M., Fox K.A., Cannon C.P., Klein W., Lopez-Sendon J., Montalescot G., White K., and Goldberg R.J. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24 (2003) 1815-1823
13. Health. United States 2005 with Chartbook on Trends in the Health of Americans (2005), US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Washington DC DHHS Publication No. 2005-1232
14. Carulli L., Rondinella S., Lombardini S., Canedi I., Loria P., and Carulli N. Review article: diabetes, genetics and ethnicity. Aliment Pharmacol Ther 22 suppl 2 (2005) 16-19
15. Neel J.V. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?. Am J Hum Genet 14 (1962) 353-362
16. Bild D.E., Detrano R., Peterson D., Guerci A., Liu K., Shahar E., Ouyang P., Jackson S., and Saad M.F. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111 (2005) 1313-1320
17. Carnethon M.R., Bertoni A.G., Shea S., Greenland P., Ni H., Jacobs Jr. D.R., Saad M., and Liu K. Racial/ethnic differences in subclinical atherosclerosis among adults with diabetes: the multiethnic study of atherosclerosis. Diabetes Care 28 (2005) 2768-2770
18. McClelland R.L., Chung H., Detrano R., Post W., and Kronmal R.A. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 113 (2006) 30-37
19. Rajagopal V., Lincoff A.M., Cohen D.J., Gurm H.S., Hu T., Desmet W.J., Kleiman N.S., Bittl J.A., Feit F., and Topol E.J. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. Am Heart J 152 (2006) 149-154
20. Stone P.H., Thompson B., Anderson H.V., Kronenberg M.W., Gibson R.S., Rogers W.J., Diver D.J., Theroux P., Warnica J.W., Nasmith J.B., et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III registry. JAMA 275 (1996) 1104-1112
21. Vaccarino V., Rathore S.S., Wenger N.K., Frederick P.D., Abramson J.L., Barron H.V., Manhapra A., Mallik S., and Krumholz H.M. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 353 (2005) 671-682
22. Sada M.J., French W.J., Carlisle D.M., Chandra N.C., Gore J.M., and Rogers W.J. Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. Participants in the National Registry of Myocardial Infarction. J Am Coll Cardiol 31 (1998) 1474-1480
23. Christian J.B., Lapane K.L., and Toppa R.S. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke 34 (2003) 2693-2697
24. Gadegbeku C., Freeman M., and Agodoa L. Racial disparities in renal replacement therapy. J Natl Med Assoc 94 suppl (2002) 45S-54S
25. Chenhsu R.Y., Chiang S.C., Chou M.H., and Lin M.F. Long-term treatment with warfarin in Chinese population. Ann Pharmacother 34 (2000) 1395-1401
26. Dang M.T., Hambleton J., and Kayser S.R. The influence of ethnicity on warfarin dosage requirement. Ann Pharmacother 39 (2005) 1008-1012